Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Berenguer, J; von Wichmann, MA; Quereda, C; Miralles, P; Mallolas, J; Lopez-Aldeguer, J; Alvarez-Pellicer, J; De Miguel, J; Crespo, M; Guardiola, JM; Tellez, MJ; Galindo, MJ; Arponen, S; Barquilla, E; Bellon, JM; Gonzalez-Garcia, J.

Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2011; 66(12): 2843-2849 Nº de citas: 13 [doi:10.1093/jac/dkr362]

Sobrino-Vegas, P; Gutierrez, F; Berenguer, J; Labarga, P; Garcia, F; Alejos-Ferreras, B; Munoz, MA; Moreno, S; del Amo, J.

The cohort of the spanish hiv research network (coris) and its associated biobank; organizational issues, main findings and losses to follow-up

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2011; 29(9): 645-653 Nº de citas: 141 [doi:10.1016/j.eimc.2011.06.002]

Mugavero, MJ; May, M; Ribaudo, HJ; Gulick, RM; Riddler, SA; Haubrich, R; Napravnik, S; Abgrall, S; Phillips, A; Harris, R; Gill, MJ; de Wolf, F; Hogg, R; Gunthard, HF; Chene, G; Monforte, AD; Guest, JL; Smith, C; Murillas, J; Berenguer, J; Wyen, C; Domingo, P; Kitahata, MM; Sterne, JAC; Saag, MS.

Comparative Effectiveness of Initial Antiretroviral Therapy Regimens: ACTG 5095 and 5142 Clinical Trials Relative to ART-CC Cohort Study

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2011; 58(3): 253-260 Nº de citas: 20 [doi:10.1097/QAI.0b013e318230372e]

Gomez, CE; Najera, JL; Perdiguero, B; Garcia-Arriaza, J; Sorzano, COS; Jimenez, V; Gonzalez-Sanz, R; Jimenez, JL; Munoz-Fernandez, MA; de Quiros, JCLB; Guardo, AC; Garcia, F; Gatell, JM; Plana, M; Esteban, M.

The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens

Journal of Virology. 2011; 85(21): 11468-11478 Nº de citas: 68 [doi:10.1128/JVI.05165-11]

Resino, S; Asensio, C; Bellon, JM; Carmona, R; Miralles, P; Lopez, JC; Cosin, J; Alvarez, E; Berenguer, J.

Diagnostic accuracy of the APRI, FIB-4, and the Forns index for predicting liver fibrosis in HIV/HCV-coinfected patients: A validation study

JOURNAL OF INFECTION. 2011; 63(5): 402-405 Nº de citas: 18 [doi:10.1016/j.jinf.2011.07.017]

Garcia, F; de Quiros, JCLB; Gomez, CE; Perdiguero, B; Najera, JL; Jimenez, V; Garcia-Arriaza, J; Guardo, AC; Perez, I; Diaz-Brito, V; Conde, MS; Gonzalez, N; Alvarez, A; Alcami, J; Jimenez, JL; Pich, J; Arnaiz, JA; Maleno, MJ; Leon, A; Munoz-Fernandez, MA; Liljestrom, P; Weber, J; Pantaleo, G; Gatell, JM; Plana, M; Esteban, M.

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pot and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)

VACCINE. 2011; 29(46): 8309-8316 Nº de citas: 81 [doi:10.1016/j.vaccine.2011.08.098]

Guzman-Fulgencio, M; Berenguer, J; Garcia-Alvarez, M; Micheloud, D; Lopez, JC; Cosin, J; de Castro, IF; Catalan, P; Miralles, P; Resino, S.

Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2011; 30(10): 1213-1221 Nº de citas: 4 [doi:10.1007/s10096-011-1215-0]

Tejerina, F; de Quiros, JCLB.

Protease Inhibitors as Preferred Initial Regimen for Antiretroviral-Naive HIV Patients

AIDS REVIEWS. 2011; 13(4): 227-233 Nº de citas: 10

Sanchez-Conde, M; Miralles, P; Bellon, JM; Rincon, D; Ramirez, M; Gutierrez, I; Ripoll, C; Lopez, JC; Cosin, J; Clemente, G; Lo Iacono, O; Banares, R; Berenguer, J.

Use of transient elastography (FibroScan (R)) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients

JOURNAL OF VIRAL HEPATITIS. 2011; 18(10): 685-691 Nº de citas: 51 [doi:10.1111/j.1365-2893.2010.01371.x]

Garcia-Alvarez, M; Guzman-Fulgencio, M; Berenguer, J; Micheloud, D; Campos, Y; Lopez, JC; Cosin, J; Miralles, P; Alvarez, E; Resino, S.

European mitochondrial DNA haplogroups and liver fibrosis in HIV and hepatitis C virus coinfected patients

AIDS. 2011; 25(13): 1619-1626 Nº de citas: 14 [doi:10.1097/QAD.0b013e328349820f]

Sanchez-Conde, M; Ramirez, MLM; Cano, JMB; Caminoa, A; Rodriguez, FA; Garcia, JG; Martin, PM; de la Serna, IB; de Quiros, JCLB; Lopez, JRA; Ochaita, JC; Pareja, JFP; Alvarez, E; Berenguer, JB.

Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus

JOURNAL OF VIRAL HEPATITIS. 2011; 18(7): 278-283 Nº de citas: 32 [doi:10.1111/j.1365-2893.2010.01407.x]

Garcia-Alvarez, M; Berenguer, J; Guzman-Fulgencio, M; Micheloud, D; Catalan, P; Munoz-Fernandez, MA; Alvarez, E; Resino, S.

High plasma fractalkine (CX3CL1) levels are associated with severe liver disease in HIV/HCV co-infected patients with HCV genotype 1

CYTOKINE. 2011; 54(3): 244-248 Nº de citas: 17 [doi:10.1016/j.cyto.2011.03.001]

Cachafeiro, SP; Caro-Murillo, AM; Berenguer, J; Segura, F; Gutierrez, F; Vidal, F; Martinez-Perez, MA; Sola, J; Muga, R; Moreno, S; Del Amo, J.

Association of Patients' Geographic Origins with Viral Hepatitis Co-infection Patterns, Spain

EMERGING INFECTIOUS DISEASES. 2011; 17(6): 1116-1119 Nº de citas: 6 [doi:10.3201/eid1706.091810]

Lopez-Dieguez, M; Montes, ML; Pascual-Pareja, JF; Quereda, C; Von Wichmann, MA; Berenguer, J; Tural, C; Hernando, A; Gonzalez-Garcia, J; Serrano, L; Arribas, JR.

The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients

AIDS. 2011; 25(7): 899-904 Nº de citas: 65 [doi:10.1097/QAD.0b013e3283454174]

Guzman-Fulgencio, M; Berenguer, J; de Castro, IF; Micheloud, D; Lopez, JC; Cosin, J; Miralles, P; Lorente, R; Aldamiz-Echevarria, T; Munoz-Fernandez, MA; Resino, S.

Sustained virological response to interferon-alpha plus ribavirin decreases inflammation and endothelial dysfunction markers in HIV/HCV co-infected patients

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2011; 66(3): 645-649 Nº de citas: 27 [doi:10.1093/jac/dkq518]

Alonso, M; Rodriguez-Sanchez, B; Giannella, M; Catalan, P; Gayoso, J; de Quiros, JCLB; Bouza, E; de Viedma, DG.

Resistance and virulence mutations in patients with persistent infection by pandemic 2009 A/H1N1 influenza

JOURNAL OF CLINICAL VIROLOGY. 2011; 50(2): 114-118 Nº de citas: 21 [doi:10.1016/j.jcv.2010.10.007]

Parra, J; Portilla, J; Pulido, F; Sanchez-de la Rosa, R; Alonso-Villaverde, C; Berenguer, J; Blanco, JL; Domingo, P; Dronda, F; Galera, C; Gutierrez, F; Kindelan, JM; Knobel, H; Leal, M; Lopez-Aldeguer, J; Marino, A; Miralles, C; Molto, J; Ortega, E; Oteo, JA.

Clinical Utility of Maraviroc

CLINICAL DRUG INVESTIGATION. 2011; 31(8): 527-542 Nº de citas: 28 [doi:10.2165/11590700-000000000-00000]

Resino, S; Seoane, JA; Bellon, JM; Dorado, J; Martin-Sanchez, F; Alvarez, E; Cosin, J; Lopez, JC; Lopez, G; Miralles, P; Berenguer, J.

An artificial neural network improves the non-invasive diagnosis of significant fibrosis in HIV/HCV coinfected patients

JOURNAL OF INFECTION. 2011; 62(1): 77-86 Nº de citas: 30 [doi:10.1016/j.jinf.2010.11.003]